T P Pretlow

发表

5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia.

M. Resnick, T. P. Pretlow, T. Pretlow, 1989, Cancer research.

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

S. Schwartz, M. Resnick, T. P. Pretlow, 1996, Cancer research.

Expression of E-cadherin in primary and metastatic prostate cancer.

T. P. Pretlow, S. Amini, T. Pretlow, 1996, The American journal of pathology.

Beta-catenin expression is altered in human colonic aberrant crypt foci.

T. P. Pretlow, T. Pretlow, J. S. Rao, 2001, Cancer research.

Altered expression of CD44 in human prostate cancer during progression.

T. P. Pretlow, S. Amini, T. Pretlow, 1996, American journal of clinical pathology.

Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells.

T. P. Pretlow, T. Pretlow, L. Culp, 1990, Journal of the National Cancer Institute.

Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.

T. P. Pretlow, T. Pretlow, L. Culp, 1990, Cancer research.

Recovery of nuclei from glycol-methacrylate-embedded tissue.

T. P. Pretlow, T. Pretlow, J. Jacobberger, 1990, Blood.

Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer.

I. Siu, T. Stellato, A. K. Konstantakos, 1996, Gastroenterology.